GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius Stedim Biotech SA (STU:56S1) » Definitions » Other Financing

Sartorius Stedim Biotech (STU:56S1) Other Financing : €-246 Mil (TTM As of Mar. 2025)


View and export this data going back to 2009. Start your Free Trial

What is Sartorius Stedim Biotech Other Financing?

Sartorius Stedim Biotech's Other Financing for the three months ended in Mar. 2025 was €-10 Mil.

Sartorius Stedim Biotech's Other Financing for the trailing twelve months (TTM) ended in Mar. 2025 was €-246 Mil.

Sartorius Stedim Biotech Other Financing Historical Data

The historical data trend for Sartorius Stedim Biotech's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius Stedim Biotech Other Financing Chart

Sartorius Stedim Biotech Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -34.06 -9.50 -52.40 -205.30 -177.80

Sartorius Stedim Biotech Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.40 -94.60 -133.10 -8.80 -9.90

Sartorius Stedim Biotech Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-246 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sartorius Stedim Biotech Other Financing Related Terms

Thank you for viewing the detailed overview of Sartorius Stedim Biotech's Other Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Sartorius Stedim Biotech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius Stedim Biotech SA (STU:56S1) » Definitions » Other Financing
Comparable Companies
XPAR:AMPLI XPAR:ALCJ XPAR:MLBON XPAR:ALSPW XPAR:ALSAF ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD TSE:4543 OCSE:COLO B XSWX:STMN BAX COO WST XTER:SRT HOLX SOLV
Traded in Other Exchanges
SRTOY:USA SDMHF:USA DIMp:UK 0RG8:UK DIM:France 56S1:Germany DIM:Austria
Address
Otto-Brenner-Strasse 20, Goettingen, DEU, 37079
Website
https://www.sartorius.com
Sartorius Stedim Biotech, or SSB, is a leading provider of bioprocessing solutions. Its sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs, and has a focus on single-use technology, or SUT. It is a subsidiary of Sartorius AG, which has a 74% ownership and 85% voting control. The business is geographically diverse.

Sartorius Stedim Biotech Headlines

No Headlines